uCT ATLAS Astound with uWS-CT-Dual Energy Analysis

The uCT ATLAS Astound system provides comprehensive whole-body computed tomography imaging, including specialized low-dose lung cancer screening and advanced cardiac applications, by utilizing rapid scanning and AI-enhanced image reconstruction. Its integrated uWS-CT-Dual Energy Analysis software further enables detailed material composition analysis through post-processing of multi-energy CT data, aiding in the differentiation of tissue types and pathological conditions.

The uCT ATLAS Astound is a multi-slice computed tomography (CT) x-ray system designed for producing cross-sectional images of the whole body, including head, cardiac, and vascular applications, as well as low-dose CT lung cancer screening for early nodule detection. It utilizes computer reconstruction of x-ray transmission data acquired from various angles and planes. Key features include a 40mm z-coverage Z-Detector, rapid 0.25s rotation speed, fast helical scanning capabilities, an 82cm bore, and uAI Vision for patient positioning assistance, all aimed at reducing radiation dose and enhancing scanning efficiency for applications like cardiac and dynamic whole organ imaging. Complementing the scanner, the uWS-CT-Dual Energy Analysis is a post-processing software package. It processes CT images acquired at different tube voltages and/or currents of the same anatomical region to analyze the chemical composition of tissues by leveraging variations in x-ray attenuation coefficients at different energy levels. This software combines low and high energy spectra images to visualize material differences, offering functionalities such as generating mono-energetic images, virtual non-contrast images, and analyzing material pairs (e.g., uric acid-calcium) for applications like kidney stone and gout assessment. The system incorporates the Deep IR (AIIR) reconstruction method, which integrates model-based iterative reconstruction with deep learning to minimize image noise and artifacts, thereby improving low-contrast detectability and spatial resolution.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the Deep IR (AIIR) reconstruction method, which combines model-based iterative reconstruction and deep learning, quantitatively compare to traditional reconstruction algorithms in terms of noise reduction, low-contrast detectability, and spatial resolution across different anatomical regions and patient BMIs?; What is the specific range of energy spectra (kVp settings) utilized by the uWS-CT-Dual Energy Analysis software, and how does the system optimize these settings for different material differentiation tasks, such as distinguishing uric acid from calcium in renal calculi?; Could the reduced detector z-coverage (40mm) and fewer detector rows (80) of the uCT ATLAS Astound compared to its predicate device impact the temporal resolution or motion artifact susceptibility in dynamic whole organ imaging or cardiac CT, and what strategies are employed to mitigate these potential limitations?; What are the performance characteristics (e.g., sensitivity, specificity, accuracy) of the uWS-CT-Dual Energy Analysis software in identifying and characterizing specific material compositions, such as uric acid in gout or differentiating types of kidney stones, based on clinical image evaluations?; Given the uCT ATLAS Astound is intended for low-dose CT lung cancer screening, what are the typical effective dose values achieved for this specific application, and how do these compare to established diagnostic reference levels or other low-dose CT systems?